Truist Financial
INSP icon

Truist Financial’s Inspire Medical Systems INSP Stock Holding History

Truist Financial’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
10,203
-157
-2% -$7.45K ﹤0.01% 2263
2026
Q1 		$534K Buy
+10,360
New +$725K ﹤0.01% 2054
2025
Q4 		– Sell
-5,299
Closed -$393K – 2811
2025
Q3 		$393K Buy
5,299
+2,532
+92% +$256K ﹤0.01% 2165
2025
Q2 		$359K Sell
2,767
-1,465
-35% -$212K ﹤0.01% 2123
2025
Q1 		$674K Buy
4,232
+1,806
+74% +$327K ﹤0.01% 1714
2024
Q4 		$450K Sell
2,426
-277
-10% -$53.8K ﹤0.01% 1948
2024
Q3 		$570K Sell
2,703
-1,922
-42% -$334K ﹤0.01% 1791
2024
Q2 		$619K Sell
4,625
-1,190
-20% -$225K ﹤0.01% 1848
2024
Q1 		$1.25M Sell
5,815
-2,607
-31% -$511K ﹤0.01% 1506
2023
Q4 		$1.71M Sell
8,422
-2,034
-19% -$330K ﹤0.01% 1332
2023
Q3 		$2.07M Buy
10,456
+2,343
+29% +$591K ﹤0.01% 1213
2023
Q2 		$2.63M Sell
8,113
-657
-7% -$188K ﹤0.01% 1129
2023
Q1 		$2.05M Sell
8,770
-1,502
-15% -$380K ﹤0.01% 1222
2022
Q4 		$2.59M Sell
10,272
-2,615
-20% -$558K ﹤0.01% 1081
2022
Q3 		$2.29M Sell
12,887
-297
-2% -$59.7K ﹤0.01% 1100
2022
Q2 		$2.41M Buy
13,184
+1,580
+14% +$315K ﹤0.01% 1119
2022
Q1 		$2.98M Buy
11,604
+654
+6% +$149K ﹤0.01% 1108
2021
Q4 		$2.52M Buy
10,950
+565
+5% +$138K ﹤0.01% 1178
2021
Q3 		$2.42M Buy
10,385
+2,677
+35% +$559K ﹤0.01% 1181
2021
Q2 		$1.49M Buy
7,708
+1,199
+18% +$238K ﹤0.01% 1438
2021
Q1 		$1.35M Buy
6,509
+1,958
+43% +$416K ﹤0.01% 1414
2020
Q4 		$857K Sell
4,551
-252
-5% -$41.2K ﹤0.01% 1559
2020
Q3 		$619K Buy
4,803
+1,820
+61% +$201K ﹤0.01% 1613
2020
Q2 		$260K Buy
+2,983
New +$229K ﹤0.01% 2050
2020
Q1 		– Sell
-5,096
Closed -$379K – 2480
2019
Q4 		$379K Buy
+5,096
New +$328K ﹤0.01% 2029

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Truist Financial's INSP Position: Q2 2026 in Review

Truist Financial reduced its Inspire Medical Systems (INSP) stake by 1.5% in Q2 2026, selling an estimated $7.45K and leaving 10,203 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Truist Financial first reported a position in INSP in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.98M in Q1 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Truist Financial held 10,203 shares of Inspire Medical Systems worth $455K as of Q2 2026.
  • Truist Financial sold 157 Inspire Medical Systems shares in Q2 2026, an estimated $7.45K.
  • Inspire Medical Systems made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2263 holding.
  • Truist Financial first reported a position in Inspire Medical Systems in Q4 2019 and has held it in 25 quarters since.
  • Truist Financial's Inspire Medical Systems position peaked at $2.98M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.